An older adult client is admitted to the cardiac intensive care unit with cardiogenic shock and pulmonary edema. The client has a single-lumen peripheral venous catheter continuously infusing dobutamine. Assessment reveals a blood pressure of 82/48 mm Hg, severe orthopnea, and coarse crackles throughout both lung fields. The provider orders an immediate intravenous push of bumetanide. Drug reference materials indicate bumetanide is physically incompatible with dobutamine. Which action demonstrates the safest administration technique?
- Establish a new, separate peripheral intravenous catheter to administer the bumetanide.Answer
- BStop the dobutamine infusion temporarily, flush the line with normal saline, push the bumetanide, flush again, and restart the dobutamine.
- CConnect the bumetanide to the lowest Y-site port on the primary tubing for simultaneous administration.
- DContact the healthcare provider to request converting the bumetanide to an oral formulation.
Answer
Establish a new, separate peripheral intravenous catheter to administer the bumetanide.
Securing a separate intravenous access site is the only safe intervention. Dobutamine is a critical inotropic medication with a short half-life used to maintain cardiac output and blood pressure in cardiogenic shock. Interrupting this infusion, even briefly to administer another drug, can precipitate rapid hemodynamic collapse. Furthermore, because bumetanide and dobutamine are incompatible, they cannot share the same line simultaneously.
Step-by-Step Solution
Key Concept
Management of Incompatible Vasoactive Intravenous Infusions